Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

This journal supports open access

Editor-in-Chief:

Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
ICCF-CNRS UMR 6296
Université Clermont Auvergne
Clermont-Ferrand
France

Back

Become EABM
Become Reviewer



Editorial (Thematic Issue: Phytochemicals, Intracellular Signalling Pathways and Anti-Cancer Effects) free to download

Volume:14   Issue:6
Pp: 777-778
Jiezhong Chen
DOI: 10.2174/187152061406140612171043

Curcumin: A Promising Agent Targeting Cancer Stem Cells

Volume:14   Issue:6
Pp: 787-792
Shufei Zang, Tao Liu, Junping Shi and Liang Qiao
DOI: 10.2174/1871520614666140521114735

Garlic-Derived Allyl Sulfides in Cancer Therapy

Volume:14   Issue:6
Pp: 793-799
Hai-Xia Cao, Ke-Xiang Zhu, Jian-Gao Fan and Liang Qiao
DOI: 10.2174/1871520614666140521120811

The Effect of Lycopene on the PI3K/Akt Signalling Pathway in Prostate Cancer

Volume:14   Issue:6
Pp: 800-805
Jiezhong Chen, Adam O’Donoghue, Yi-Fu Deng, Bing Zhang, Fanning Kent and Tim O’Hare
DOI: 10.2174/1871520614666140521121317

Nanoparticle-Delivered Quercetin for Cancer Therapy

Volume:14   Issue:6
Pp: 826-832
Ke Men, Xingmei Duan, Xia Wei Wei, Ma Ling Gou, Mei Juan Huang, Li Juan Chen, Zhi Yong Qian and Yu Quan Wei
DOI: 10.2174/1871520614666140521122932

Paris polyphylla: Chemical and Biological Prospectives

Volume:14   Issue:6
Pp: 833-839
Jagmohan S. Negi, Vinod K. Bisht, Arvind K. Bhandari, Vijay P. Bhatt, Pramod Singh and Narayan Singh
DOI: 10.2174/1871520614666140611101040



Preclinical Development of Novel Rac1-GEF Signaling Inhibitors using a Rational Design Approach in Highly Aggressive Breast Cancer Cell Lines open access plus

Volume:14   Issue:6
Pp: 840-851
Georgina A. Cardama, Maria J. Comin, Leandro Hornos, Nazareno Gonzalez, Lucas Defelipe, Adrian G. Turjanski, Daniel F. Alonso, Daniel E. Gomez and Pablo Lorenzano Menna
DOI: 10.2174/18715206113136660334



Targetability and Biodistribution of Radioiodinated Hypericin: Comparison between Microdosing and Carrier-Added Preparations

Volume:14   Issue:6
Pp: 852-861
Marlein Miranda Cona, Junjie Li, Yuanbo Feng, Feng Chen, Alfons Verbruggen, Peter de Witte, Raymond Oyen and Yicheng Ni
DOI: 10.2174/18715206113136660360

The Indolylcoumarin COUFIN Exhibits Potent Activity Against Renal Carcinoma Cells without Affecting Hematopoietic System

Volume:14   Issue:6
Pp: 862-871
Pierre Champelovier, Pascale Barbier, Etienne Daras, Soazig Douillard, Bertrand Toussaint, Virginie Persoon, Veronique Curri, Vincent Peyrot and Sebastien Combes
DOI: 10.2174/1871520614666140223190829



Design and Development of Oxazol-5-Ones as Potential Partial PPAR-γ Agonist Against Cancer Cell Lines

Volume:14   Issue:6
Pp: 872-883
Tanushree Pal, Hardik Joshi and C.S. Ramaa
DOI: 10.2174/1871520614666140528155118



miR-1271 Regulates Cisplatin Resistance of Human Gastric Cancer Cell Lines by Targeting IGF1R, IRS1, mTOR, and BCL2

Volume:14   Issue:6
Pp: 884-891
Mifang Yang, Xia Shan, Xin Zhou, Tianzhu Qiu, Wei Zhu, Yin Ding, Yongqian Shu and Ping Liu
DOI: 10.2174/1871520614666140528161318



The Design and Characterization of a Novel beta-casein Nano-vehicle Loaded with Platinum Anticancer Drug for Drug Delivery

Volume:14   Issue:6
Pp: 892-900
Adeleh Divsalar, Mahdieh Razmi, Ali Akbar Saboury and Arefeh Seyedarabi
DOI: 10.2174/1871520614666140207123147



Role of Caspases, Bax and Bcl-2 in Chrysin-Induced Apoptosis in the A549 Human Lung Adenocarcinoma Epithelial Cells

Volume:14   Issue:6
Pp: 901-909
Saeed Samarghandian, Mohsen Azimi Nezhad and Gholamreza Mohammadi
DOI: 10.2174/1871520614666140209144042



Synthesis and Stereochemistry-Activity Relationship of Chiral Thiourea Derivatives as Potential Anticancer Agents

Volume:14   Issue:6
Pp: 910-920
Vikas Kumar, Akshay Kumar, Vommina V. Sureshbabu and Swapandeep S. Chimni
DOI: 10.2174/18715206113136660368